Humacyte reported a 151% increase in Symvess sales revenue to $1.0 million in Q3 2026, driven by expanded hospital adoption. The company plans to file a supplemental Biologics License Application with the FDA in November 2026 for its ATEV device in dialysis access, supported by positive Phase 3 trial results. Additionally, Humacyte initiated a Phase 2a clinical study for its coronary artery bypass grafting product. The momentum in commercial sales is expected to continue into Q4 2026 with further hospital additions and increased physician engagement.
Humacyte's Q3 2026 results show a 151% rise in Symvess revenue to $1.0 million. For readers following the health sector, 85 of 150 US health stocks traded on Pluang rose today. Notable movers include FLNA at USD 0.53 with a 7.80% increase and CGC at USD 0.65 with a 4.37% rise, as of Nov 10, 2026 18:42 WIB.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
